/Investor DB

Amino Capital — 2019 Investments

2 investments dated 2019 · listed companies and verified rows first · show all

Apostleapostlebio.cominMay 2019

Apostle develops cell-free DNA (cfDNA) extraction and purification kits for genomics and molecular biology laboratories.

BiotechHealthtechMedical DevicesMenlo Park, US

Dongliang Ge(Executive Officer, Director)Wenqi (Wayne) Zeng(Founder)inDavid GeinXin Guo(Director)Bo Zhang(Executive Officer, Director)

BoardWilliam Dai(Director)in

Co-investorsShangBay Capital LLCStartX

GetAcceptgetaccept.comin𝕏Pre-Seed · Jan 2019 · $120K

GetAccept operates a Digital Sales Room platform that helps sales teams close deals by sharing sales content with personalized video, live chat, and e-signature.

AI & Machine LearningEnterprise SoftwareSaaSSales TechSan Francisco, US

Samir Smajic(CEO)inCarl Carell(Founder)inMathias Thulin(Executive Partner)inJonas Blanck(Founder)in

BoardThomas Rubens(Director)in

Co-investorsBessemer Venture PartnersDN CapitalY CombinatorBootstrapLabs

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.